Scope of Activities

HKCREC is open to any investigator or medical institution. Subject to the conditions of this SOP, HKCREC undertakes to perform ethics and scientific review and oversight of clinical studies undertaken by investigators or medical institutions that commit to comply with the requirements of HKCREC in writing. For the avoidance of doubt, HKCREC’s review and approval shall not release an investigator/institution from the responsibility of obtaining other necessary approvals for a study.

Our Services

  • Responsibilities

    • To protect the rights, safety and well-being of human subjects with respect to their participation in clinical studies under its jurisdiction through:

      • receiving applications for initial review of clinical studies from principal investigators, performing initial ethics and scientific review of such studies, and giving its decision(s)/opinion(s) on each application;

      • performing continuous ethics and scientific oversight during the period of each approved clinical study and giving its decision(s)/opinion(s);

      • creating and maintaining necessary records with respect to ethics and scientific review and oversight of clinical studies;

      • allowing and facilitating inspections by competent regulatory authorities; and

      • performing other duties related to ethics and scientific review and oversight of clinical studies.

  • Power

    • To request for, collect and review information, documents and materials necessary for performance of ethics and scientific review and oversight;

    • To recommend modifications to study designs and arrangements on sound ethical or scientific basis and in line with HKCREC’s mission;

    • To approve or disapprove clinical studies and give other opinions with respect to the ethical and scientific aspects of such clinical studies;

    • To suspend or terminate any approved clinical study if unacceptable risk to subjects arises;

    • To audit clinical studies to assess compliance with study protocols, HKCREC’s requirements and other applicable standards and requirements;

    • To disclose information of clinical studies to competent regulatory authorities; and exercise other authorities related to ethics and scientific review and oversight of clinical studies.

Download Area

All submissions require 1 hardcopy of document(s) with cover letter to our new mailing address (1 Jun 2023 onwards): Level 1, 28 Stanley Street, Central, Hong Kong

and, submit 1 e-copy via email at info@hkcrec.com

Meeting Schedule 2024